Rabbit anti-human T-lymphocyte globulin and hematopoietic transplantation.
作者信息
Locatelli Franco, Merli Pietro, Bertaina Alice
机构信息
Franco Locatelli: Dipartimento di Oncoematologia Pediatrica, IRCCS Ospedale "Bambino Gesù", Roma, Italy; Università degli Studi di Pavia, Pavia, Italy.
出版信息
Oncotarget. 2017 Sep 14;8(57):96460-96461. doi: 10.18632/oncotarget.20878. eCollection 2017 Nov 14.
Abstract
摘要
相似文献
1
Rabbit anti-human T-lymphocyte globulin and hematopoietic transplantation.
Oncotarget. 2017 Sep 14;8(57):96460-96461. doi: 10.18632/oncotarget.20878. eCollection 2017 Nov 14.
2
CD4+CD25+ regulatory T cell depletion improves the graft-versus-tumor effect of donor lymphocytes after allogeneic hematopoietic stem cell transplantation.
Sci Transl Med. 2010 Jul 21;2(41):41ra52. doi: 10.1126/scitranslmed.3001302.
3
Comparison of efficacy and safety between rabbit anti-thymocyte globulin and anti-T lymphocyte globulin in kidney transplantation from donation after cardiac death: a retrospective cohort study.
Nephrology (Carlton). 2015 Aug;20(8):539-43. doi: 10.1111/nep.12469.
4
Matched and mismatched allogeneic stem-cell transplantation from unrelated donors using combined graft-versus-host disease prophylaxis including rabbit anti-T lymphocyte globulin.
J Clin Oncol. 2003 Feb 1;21(3):506-13. doi: 10.1200/JCO.2003.03.129.
5
In vivo T cell depletion with low-dose rabbit antithymocyte globulin results in low transplant-related mortality and low relapse incidence following unrelated hematopoietic stem cell transplantation.
J Hematother Stem Cell Res. 2002 Aug;11(4):731-7. doi: 10.1089/15258160260194884.
6
Clinical impact of human Jurkat T-cell-line-derived antithymocyte globulin in multiple myeloma patients undergoing allogeneic stem cell transplantation.
Haematologica. 2008 Sep;93(9):1343-50. doi: 10.3324/haematol.12665. Epub 2008 Jul 18.
7
8
Rabbit anti-T cell globulin in allogeneic hematopoietic cell transplantation.
Biol Blood Marrow Transplant. 2015 Jun;21(6):959-70. doi: 10.1016/j.bbmt.2014.11.676. Epub 2014 Dec 5.
9
Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft.
N Engl J Med. 2001 Mar 22;344(12):881-8. doi: 10.1056/NEJM200103223441203.
10
Rabbit anti-T-lymphocyte globulin (ATG) persists with differential reactivity in patients' sera after full hematopoetic regeneration from allogeneic stem cell transplantation.
Transpl Immunol. 2014 May;30(4):136-9. doi: 10.1016/j.trim.2014.03.005. Epub 2014 Apr 13.
引用本文的文献
1
Impact of Anti-T-lymphocyte globulin dosing on GVHD and Immune reconstitution in matched unrelated myeloablative peripheral blood stem cell transplantation.
Bone Marrow Transplant. 2022 Oct;57(10):1548-1555. doi: 10.1038/s41409-022-01666-x. Epub 2022 Jul 13.
2
The Role of Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Leukemia.
J Clin Med. 2021 Aug 25;10(17):3790. doi: 10.3390/jcm10173790.
3
Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic Leukemia.
Curr Hematol Malig Rep. 2019 Apr;14(2):94-105. doi: 10.1007/s11899-019-00502-2.
本文引用的文献
1
Efficacy of two different doses of rabbit anti-T-lymphocyte globulin to prevent graft-versus-host disease in children with haematological malignancies transplanted from an unrelated donor: a multicentre, randomised, open-label, phase 3 trial.
Lancet Oncol. 2017 Aug;18(8):1126-1136. doi: 10.1016/S1470-2045(17)30417-5. Epub 2017 Jul 10.
2
Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease.
N Engl J Med. 2016 Jan 7;374(1):43-53. doi: 10.1056/NEJMoa1506002.
3
Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: a randomised, controlled, open-label, phase 3, multicentre trial.
Lancet Oncol. 2016 Feb;17(2):164-173. doi: 10.1016/S1470-2045(15)00462-3. Epub 2015 Dec 24.
4
Association between anti-thymocyte globulin exposure and CD4+ immune reconstitution in paediatric haemopoietic cell transplantation: a multicentre, retrospective pharmacodynamic cohort analysis.
Lancet Haematol. 2015 May;2(5):e194-203. doi: 10.1016/S2352-3026(15)00045-9. Epub 2015 Apr 21.
5
Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial.
Lancet Oncol. 2009 Sep;10(9):855-64. doi: 10.1016/S1470-2045(09)70225-6. Epub 2009 Aug 18.
6
Antithymocyte globulin induces complement-dependent cell lysis and caspase-dependent apoptosis in myeloma cells.
Exp Hematol. 2005 Dec;33(12):1531-6. doi: 10.1016/j.exphem.2005.08.004.
7
Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO).
Blood. 2001 Nov 15;98(10):2942-7. doi: 10.1182/blood.v98.10.2942.
Zotero 插件